Building on the success of our “Cracking the EMA Code” articles, Partner Rare is thrilled to present a new opportunity for busy global biotech and pharma leaders to master the European rare disease landscape.
6 Expert-Led Webinars | August & September
Join our team of seasoned rare disease veterans for a deep dive into the critical aspects of the European market.
Designed for US and APAC biotech/pharma leaders, this webinar series demystifies the complexities of launching rare disease therapies in Europe. Gain expert insights on market entry, regulatory compliance, clinical trials, market access, patient advocacy, legal considerations, and drug repurposing. Equip your team with the knowledge and tools needed to confidently navigate the European landscape and accelerate your therapy’s impact.
This webinar series is specifically tailored for busy, non-EU-based senior leaders in biotech and pharma who are short on time but eager to learn.
14 / 08 / 2024
Rare Disease Clinical Trials, Design and Execution
Professor Boris Kramer
28 / 08 / 2024
Legal Considerations for Rare Disease Therapy Launch in Europe
Sita Shubert
02 / 09 / 2024
Drug Repurposing Rare Disease Therapies Into Europe
Keith Williams
06 / 08 / 2024
Expanding Into Europe
Professor Trevor M. Jones
08 / 08 / 2024
Demystifying the Maze, Regulatory
Agnes Kohl
14 / 08 / 2024
Rare Disease Clinical Trials, Design and Execution
Professor Boris Kramer
21 / 08 / 2024
Market Access / Patient Advocacy
Aaron Blocker
28 / 08 / 2024
Legal Considerations for Rare Disease Therapy Launch in Europe
Sita Shubert
02 / 09 / 2024
Drug Repurposing Rare Disease Therapies Into Europe
Keith Williams
Secure Your Spot Today!
Your gateway to successful rare disorder asset commercialization in the European market.
